02435nas a2200229 4500008004100000245008300041210006900124260001500193300001000208490000600218520172700224653002601951653002501977653001802002653001902020653002202039100002802061700001502089700003302104700002002137856004802157 2020 eng d00aIncidence and Assessment of Adverse Drug Reactions at a Tertiary Care Hospital0 aIncidence and Assessment of Adverse Drug Reactions at a Tertiary cApril 2020 a15-170 v63 a

Background: Adverse drug reactions have proved a significant problem in healthcare for decade. Healthcare professionals have a responsibility in use of rational drugs for their patients. Objectives: The aim of the study was to determine the prevalence of ADRs in a tertiary care hospital to determine the most common Therapeutic Class of Drugs causing ADR and to determine the most common Organ system affected by ADR. Methods: The Prospective, observational study was conducted in the wards of St. Philomena’s Hospital, Bangalore between January 2016 and August 2016. All In-patients were monitored for ADRs during their admission period. Results: Over the study period of 12 months, a total of 374 ADRs were reported in 600 patients. The ADRs observed were higher in female patients [196 (52.4%)]. A predominance of gastro- intestinal reactions [70 (18.71%)] was observed. Therapeutic classes of drugs frequently associated with ADRs were antibiotics [84(22.4%)] followed by antihypertensive agents [63 (16.84%)] and antidiabetic [37 (9.89%)]. The most common drugs involved in causing ADRs were Furosemide and Cefoperazone and the most commonly reported ADR was Diarrhoea [28 (7.4.8%)] followed by Itching 2[9 (7.75%)]. Majority of the ADRs [95 (74.80%)] were managed by withdrawing the suspected drug. The causality assessment of the ADRs were carried out using the Naranjo’s Scale algorithm and the majority of the ADRs were found to be definite [41 (32%)]. Conclusion: Continuous monitoring by a clinical pharmacist in hospital setup will reduce the occurrence of ADR and improve the patient safety.

10aAdverse drug reaction10aCausality assessment10aNaranjo scale10aPatient safety10aPharmacovigilance1 aPriyanka, Pulimi, Divya1 aVithya, T.1 aHiremath, Shobha, Rani Rajee1 aPrasad, Shankar uhttp://www.jppcm.org/article/2020/6/1/15-17